Literature DB >> 7377374

Functional reinnervation and development of supersensitivity to NE after renal denervation in rats.

R L Kline, P F Mercer.   

Abstract

The time course for functional reinnervation and development of supersensitivity to norepinephrine (NE) in the denervated rat kidney was studied using an in situ kidney preparation perfused at constant flow. Changes in perfusion pressure were measured during renal nerve stimulation (RNS, 1-10 Hz) and after administration of NE (1-50 ng, ia) up to 8 wk after unilateral renal denervation or a sham operation. During the first 2 wk after denervation, supersensitivity to NE was present, but there was no response to RNS. Between 24 and 32 days after denervation, RNS produced responses averaging 40% of control in denervated kidneys and supersensitivity to NE was still present. A fluorescence assay was used to determine that the NE concentration in kidneys 24-32 days after denervation was less than 30% of that found in control kidneys. At 8 wk, average responses to RNS in denervated kidneys were not significantly different from innervated kidneys, while supersensitivity to NE was still present. These results indicate that functional reinnervation of the renal vasculature begins to occur between 14 and 24 days after denervation, and that complete return of function may occur by 8 wk. The response to RNS during reinnervation appears to be due to a combination of regeneration of nerve fibers and denervation supersensitivity to NE.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7377374     DOI: 10.1152/ajpregu.1980.238.5.R353

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  24 in total

Review 1.  Renal afferents and hypertension.

Authors:  John Ciriello; Cleusa V R de Oliveira
Journal:  Curr Hypertens Rep       Date:  2002-04       Impact factor: 5.369

Review 2.  Key advances in antihypertensive treatment.

Authors:  Ludovit Paulis; Ulrike M Steckelings; Thomas Unger
Journal:  Nat Rev Cardiol       Date:  2012-03-20       Impact factor: 32.419

Review 3.  Renal denervation for arrhythmias: hope or hype?

Authors:  Jonathan S Steinberg; Evgeny Pokushalov; Suneet Mittal
Journal:  Curr Cardiol Rep       Date:  2013-09       Impact factor: 2.931

Review 4.  Renal denervation: intractable hypertension and beyond.

Authors:  Wassawon Ariyanon; Huijuan Mao; Zelal Adýbelli; Silvia Romano; Mariapia Rodighiero; Bernhard Reimers; Luigi La Vecchia; Claudio Ronco
Journal:  Cardiorenal Med       Date:  2014-01-15       Impact factor: 2.041

5.  Intravenous cyclosporine activates afferent and efferent renal nerves and causes sodium retention in innervated kidneys in rats.

Authors:  N G Moss; S L Powell; R J Falk
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

6.  Blood pressure decrease in spontaneously hypertensive rats folowing renal denervation or dopamine β-hydroxylase inhibition with etamicastat.

Authors:  Nuno Miguel Pires; Bruno Igreja; Eduardo Moura; Lyndon Christopher Wright; Maria Paula Serrão; Patrício Soares-da-Silva
Journal:  Hypertens Res       Date:  2015-04-09       Impact factor: 3.872

7.  Supersensitivity of the renal tubule to catecholamines in the chronically denervated canine kidney.

Authors:  G Szénási; P Bencsáth; L Takács
Journal:  Pflugers Arch       Date:  1986-01       Impact factor: 3.657

Review 8.  Renal denervation in human hypertension: mechanisms, current findings, and future prospects.

Authors:  Markus P Schlaich; Dagmara Hering; Paul A Sobotka; Henry Krum; Murray D Esler
Journal:  Curr Hypertens Rep       Date:  2012-06       Impact factor: 5.369

Review 9.  Renal denervation for the treatment of resistant hypertension: review and clinical perspective.

Authors:  Radu Iliescu; Thomas E Lohmeier; Ionut Tudorancea; Luke Laffin; George L Bakris
Journal:  Am J Physiol Renal Physiol       Date:  2015-07-29

10.  Renal sensory and sympathetic nerves reinnervate the kidney in a similar time-dependent fashion after renal denervation in rats.

Authors:  Jan Mulder; Tomas Hökfelt; Mark M Knuepfer; Ulla C Kopp
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-02-13       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.